Suchergebnisse - "Pertinez, Henry"

PubPharm (73)

11

Modelling of Systemic versus Pulmonary Chloroquine Exposure in Man for COVID-19 Dose Selection

enthalten in: bioRxiv.org | 2023

von Aljayyoussi, G. | Rajoli, R. | Pertinez, H. | +6

12

Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters

enthalten in: Viruses | 2023

von Neary, M. | Sharp, J. | Gallardo-Toledo, E. | +18

13

Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research

enthalten in: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 2023

von Neary, M. | Arshad, U. | Tatham, L. | +9

UpdateOf: bioRxiv. 2021 May 28;:. - PMID 34075381

14

Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Chang, Y. | Li, S. | Pertinez, H. | +6

UpdateOf: bioRxiv. 2023 Apr 12;:. - PMID 37090528

15

Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations

enthalten in: Pharmaceutics | 2023

von Curley, P. | Hobson, J. | Liptrott, N. | +14

16

Using dynamic oral dosing of rifapentine and rifabutin to simulate exposure profiles of long-acting formulations in a mouse model of tuberculosis preventive therapy

enthalten in: bioRxiv : the preprint server for biology | 2023

von Chang, Y. | Li, S. | Pertinez, H. | +6

UpdateIn: Antimicrob Agents Chemother. 2023 Jun 14;:e0048123. - PMID 37338374

17

Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case

enthalten in: bioRxiv : the preprint server for biology | 2023

von Tatham, L. | Kipar, A. | Sharp, J. | +14

18

Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV 2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case

enthalten in: bioRxiv.org | 2023

von Tatham, L. | Kipar, A. | Sharp, J. | +14

19

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

enthalten in: Nature | 2023

von Brevini, T. | Maes, M. | Webb, G. | +77

CommentIn: Nat Rev Drug Discov. 2023 Feb;22(2):97. - PMID 36517581

20

Optimisation and validation of a sensitive bioanalytical method for niclosamide

enthalten in: bioRxiv.org | 2022

von Arshad, U. | Pertinez, H. | Box, H. | +13